CGON

CG Oncology (CGON) Earnings

Review CG Oncology (CGON) earnings with server-rendered company data, supporting context and links to related investor research.

Annual EPS
-2.08
Trailing EPS
-2.70
Annual revenue
$4.04M
Trailing revenue
$6.23M
Next earnings date
2026-08-07
Earnings data source
MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings

CG Oncology (CGON) Earnings research

The CGON earnings page organizes the available earnings-per-share and revenue context for CG Oncology. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.

Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.